Merestinib inhibits cuproptosis by targeting NRF2 to alleviate acute liver injury
Xianyu Luo(Zhejiang Sci-Tech University), Yi‐Hsiang Huang(First Hospital of Lanzhou University), Didi Liu(Northwest University), Maoyuan Linghu(Jiangnan University), Yi Ru(Jiangnan University), Yinchu Ma(Jiangnan University), Xinru Zhou(Southern Medical University), Ying‐Li Luo(Jiangnan University)
Cited by 17
Related Papers
Four‐year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients
|Liver International|2016|225
Targeting of NLRP3 inflammasome with gene editing for the amelioration of inflammatory diseases
|Nature Communications|2018|193
African Swine Fever Virus MGF-505-7R Negatively Regulates cGAS–STING-Mediated Signaling Pathway
|The Journal of Immunology|2021|157
Identification of a targeted ACSL4 inhibitor to treat ferroptosis-related diseases
|Science Advances|2024|153
2020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populations
|Journal of the Formosan Medical Association|2020|98